Skip to main content
Bio-Gate AG logo

Bio-Gate AG — Investor Relations & Filings

Ticker · BIG1 ISIN · DE000BGAG981 LEI · 391200G5LKTIOTZOXP90 F Manufacturing
Open in API
Filings indexed 242 across all filing types
Latest filing 2008-04-08 Regulatory Filings
Country DE Germany
Listing F BIG1

About Bio-Gate AG

https://www.bio-gate.de/en/

Bio-Gate AG is a provider of innovative technologies and customized solutions for health and hygiene, specializing in antimicrobial and antiviral strategies. The company enhances materials and products by incorporating its unique silver-based technologies, such as MicroSilver BG™. Key applications are concentrated in the medical technology sector, including the coating of medical implants and wound dressings to prevent infections. The company's technologies are also utilized in derma-cosmetics and veterinary care products. Furthermore, Bio-Gate provides solutions for industrial and consumer goods, imparting antimicrobial properties to items like paints, coatings, plastics, and textiles.

Recent filings

Filing Released Lang Actions
Bio-Gate AG:Bio-Gate AG erhalt Zulassung in den USA zur Nutzung des mikroskaligen Silbers auch in nicht-medizinischen Anwendungen
Regulatory Filings Classification · 100% confidence The document is a short news release dated April 8, 2008, announcing that Bio-Gate AG received approval from the US Environmental Protection Agency (EPA) for using its micro-scale silver in non-medical applications (paints, lacquers, plastics). It is a specific corporate announcement regarding regulatory progress and market expansion, not a comprehensive periodic report (like 10-K or IR), an earnings release (ER), or a transcript (CT). Since it is a specific corporate update that doesn't fit the definitions for DIRS, DIV, CAP, MANG, or LTR, and it is not a general regulatory filing fallback (RNS) but a specific type of corporate news, the closest fit among the provided options for a specific, non-financial, non-management announcement is often the general Regulatory Filing (RNS) if no better fit exists, or sometimes it falls under a general 'News Details' category which maps best to RNS in this constrained set, as it is a regulatory update announcement. However, upon reviewing the definitions, this is a specific corporate news item about regulatory approval. It is not a Director's Dealing (DIRS), Dividend (DIV), Capital (CAP), Management change (MANG), or Legal (LTR). It is not an Earnings Release (ER) or Interim Report (IR). It is a specific announcement about regulatory progress. Given the options, and since it is a specific corporate announcement distributed via a news service (DGAP), it fits best under the general 'Regulatory Filings' (RNS) category, which serves as a fallback for specific corporate news that doesn't match the other specialized codes, or potentially a 'Report Publication Announcement' (RPA) if it were announcing the publication of a larger report, which it is not. Therefore, RNS is the most appropriate general category for this type of specific, non-periodic corporate news update.
2008-04-08 German
Bio-Gate AG: Bio-Gate AG baut Marktposition bei Kosmetika aus
Regulatory Filings Classification · 95% confidence The document is a short corporate news release dated January 24, 2008, announcing that Bio-Gate AG's subsidiary has secured five new distribution agreements in the cosmetics sector. It details business expansion and product development, typical of a press release announcing operational achievements. It is not a comprehensive annual report (10-K), an interim report (IR), an earnings release (ER) focusing on financial figures, or a formal regulatory filing like a Director's Dealing (DIRS) or Major Shareholding (MRQ). Since it is a general business update/announcement that doesn't fit the highly specific categories like AGM, M&A, or Capital Change, it falls best under the general 'Regulatory Filings' (RNS) category, which often serves as a catch-all for non-standard press releases distributed via services like DGAP.
2008-01-24 German
Bio-Gate AG: Vertragsabschluss erst 2008
Regulatory Filings Classification · 99% confidence The document is a short news release dated December 20, 2007, from Bio-Gate AG, distributed via DGAP (a German news service). It discusses an expected delay in signing a development and license agreement, leading to a slight miss on the 2007 revenue target. It also mentions the cancellation of a smaller project. This content is a timely announcement of operational and financial updates, specifically focusing on revenue outlook and contract status, rather than a comprehensive periodic report (like 10-K or IR) or a formal transcript. It fits best as an Earnings Release (ER) which covers key financial highlights/updates, or potentially a Regulatory Filing (RNS) if it were less specific. Given the focus on revenue targets and contract delays impacting results, ER is the most appropriate fit among the specific options, as it functions as an unscheduled earnings/financial update.
2007-12-20 German
Bio-Gate AG: CEO berufen
Board/Management Information Classification · 100% confidence The document is a corporate news release dated October 24, 2007, announcing a planned restructuring of the management board of Bio-Gate AG, specifically the appointment of a new CEO (Klaus Böhm) and changes in roles for other executives and founders. This content directly relates to changes in senior management personnel. According to the definitions, this falls under 'Board/Management Information' (Code: MANG). The document is not a full annual report (10-K), an earnings release (ER), or a proxy statement (DEF 14A/PSI).
2007-10-24 German
Bio-Gate AG erschliet deutschen Apotheken-Markt
Earnings Release Classification · 99% confidence The document is a short news release dated October 9, 2007, announcing the market launch of new skincare products containing Bio-Gate's MicroSilver BG™ through a product partner, leading to expected revenue and earnings impact in the current year. It is explicitly labeled as a 'Corporate News' distributed via DGAP. This type of announcement, focusing on a specific business development (product launch/sales agreement) rather than comprehensive financial results (like 10-K or IR) or a formal regulatory filing structure, best fits the 'Earnings Release' (ER) category if it were summarizing results, or potentially a general 'Regulatory Filing' (RNS) if no other category fits. However, since it announces a significant business event expected to impact revenue/earnings, and it is not a full report, it is most closely aligned with an Earnings Release (ER) which often includes forward-looking statements or immediate business updates, or potentially a general announcement. Given the options, and that it is a news release about business operations and expected financial impact, but not a formal quarterly/annual report, 'ER' (Earnings Release - initial announcement of periodical financial results/key highlights) is a plausible fit, although it is more of a product/sales update. Since it is a short news item about a business development that will contribute to revenue, and not a formal regulatory filing like a 10-K or IR, I will check other options. It is not a Call Transcript (CT), Director's Dealing (DIRS), or Dividend Notice (DIV). It is a specific business update. Given the structure and content (announcing a new revenue stream), it functions similarly to an Earnings Release announcement, even if it's not strictly quarterly results. If it were purely a press release about a partnership without the revenue mention, RNS might be better. Given the mention of 'Umsatz- und Ertragsauswirkungen' (Revenue and earnings impact), ER is the closest fit among the specific financial event codes, though RNS is a strong fallback. I will classify it as ER based on the financial impact announcement, recognizing it's a German-style news release. FY 2007
2007-10-09 German
Bio-Gate AG: Meilensteinzahlung fur weiteren Projekterfolg
Regulatory Filings Classification · 95% confidence The document is a short news release dated September 4, 2007, announcing a milestone payment received by Bio-Gate AG related to a development project for orthopedic implants. It details project progress, planned market launch, and quotes from management. It is not a full annual report (10-K), an interim report (IR), or a formal earnings release (ER) which typically contains structured financial tables. It is a specific corporate update regarding business progress and revenue recognition, which fits best under the general 'Regulatory Filings' (RNS) category as a miscellaneous corporate news item, or potentially an Earnings Release (ER) if the milestone payment is considered a key financial highlight, but given the focus on project development rather than period results, RNS is a safer general classification for non-standard announcements. However, since it announces a specific financial event (milestone payment contributing to H2 revenue), it shares characteristics with an Earnings Release (ER) or a general announcement. Given the structure (News Details, Corporate News via DGAP), and the content being a specific operational/financial update, it is most closely aligned with an Earnings Release (ER) which often includes key operational highlights alongside financial metrics, or RNS as a general announcement. Since it is not a full financial statement, and is a specific announcement, RNS is the most appropriate fallback for non-standard corporate news not covered by other specific codes like DIV, CAP, or MANG. It is a general corporate news release.
2007-09-04 German

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.